Skip to main content
CING logo

Cingulate Inc.

CINGNASDAQHealthcareBiotechnology

$4.98Today:- (-)1Y +31.01%

As of Oct 23, 2026 close

Market cap
$65.67M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$3.16$11.89
Volume (live)
-
Avg. volume (3M)
96.20K

Cingulate (CING) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Cingulate used $17.25M of cash in operating activities and spent $162.14K on capital expenditures. That left free cash flow of −$17.41M.

Cingulate Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Cingulate Inc. (CING) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2023FY 2022FY 2021FY 2020FY 2019
Period endingDec 2025Dec 2024Mar 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Operating Activities
Net Income-22.45-15.55-23.53-23.53-17.68-20.71-7.18-11.55
Depreciation & Amortization0.540.650.580.580.390.710.670.18
Deferred Income Tax0.000.000.00--0.80-16.260.000.00
Stock Based Compensation1.521.000.810.810.8012.780.000.00
Change in Working Capital0.83-4.557.107.100.60-3.21-0.291.88
Change in Accounts Receivable0.02-0.010.220.221.25-0.54-0.04-0.07
Change in Inventory0.000.000.00--1.250.000.00-0.73
Change in Accounts Payable0.000.000.005.190.79-1.32-0.451.70
Change in Other Working Capital0.81-4.546.896.89-0.19-2.670.190.98
Other Operating Activities2.310.000.00-0.8016.260.00-0.05
Net Cash from Operating Activities-17.25-18.45-15.03-15.03-15.88-10.43-6.81-9.53
Investing Activities
Capital Expenditures-0.16-0.21-0.22-0.22-0.15-0.81-0.40-1.02
Acquisitions0.000.000.00-0.000.000.00-3.76
Purchases of Investments0.000.000.00-0.000.000.02-1.55
Sales/Maturities of Investments0.000.000.00-0.000.000.025.31
Other Investing Activities0.000.000.00-0.000.000.003.76
Net Cash from Investing Activities-0.16-0.21-0.22-0.22-0.15-0.81-0.382.74
Financing Activities
Debt Repayment0.00-0.022.98-0.02-0.02-0.50-0.490.00
Common Stock Issued10.1525.886.976.97-0.0927.487.510.00
Other Financing Activities0.000.000.00-0.02-0.09-4.637.516.14
Net Cash from Financing Activities16.1530.829.959.954.9026.547.976.14
Summary
Net Change in Cash-1.2612.16-5.30-5.30-11.1415.300.78-0.64
Cash at Beginning of Period12.210.055.365.3616.491.200.421.06
Cash at End of Period10.9512.210.050.055.3616.491.200.42
Free Cash Flow-17.41-18.66-15.26-15.26-16.04-11.25-7.21-10.55
Supplemental Disclosures
Interest Paid-0.01-0.020.020.110.05-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Cingulate Cash Flow

What is Cingulate's free cash flow?

Cingulate had negative free cash flow of $17.41M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$17.25M minus $162.14K of capital expenditures.

How much does Cingulate spend on capital expenditures?

Cingulate spent $162.14K on capital expenditures in fiscal 2025, compared with $211.80K a year earlier.

Does Cingulate pay dividends or buy back shares?

Cingulate's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition